Caspofungin
CANCIDAS
Echinocandin Antifungal
NADAC/unit
N/A
No Shortage
Tier 1: 28.6%
PA Req: 18.8%
4 Manufacturers
8 ANDAs
Active Shortages
2026-01-12 Discontinuation of the manufacture of the drug, Fresenius Kabi USA, LLC
Generic Manufacturers
AREVA PHARMACEUTICALS INCFRESENIUS KABI USA LLCGLAND PHARMA LTDHANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDJIANGSU HENGRUI PHARMACEUTICALS CO LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
